213,571 Shares in GE HealthCare Technologies Inc. $GEHC Purchased by Nixon Capital LLC

Nixon Capital LLC acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 213,571 shares of the company’s stock, valued at approximately $13,671,000. GE HealthCare Technologies accounts for approximately 4.3% of Nixon Capital LLC’s holdings, making the stock its 12th largest holding.

A number of other hedge funds also recently bought and sold shares of the company. Banque Cantonale Vaudoise raised its stake in GE HealthCare Technologies by 16,539.1% during the 1st quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock valued at $1,849,000 after purchasing an additional 25,801 shares during the period. Allstate Corp lifted its holdings in shares of GE HealthCare Technologies by 100.3% in the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock valued at $2,681,000 after purchasing an additional 16,365 shares in the last quarter. Auto Owners Insurance Co boosted its position in shares of GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after buying an additional 33,629,559 shares during the period. PFA Pension Forsikringsaktieselskab acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $43,394,000. Finally, Boston Partners grew its holdings in shares of GE HealthCare Technologies by 21.7% during the fourth quarter. Boston Partners now owns 4,659,562 shares of the company’s stock valued at $382,223,000 after buying an additional 830,626 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. BNP Paribas Exane dropped their price target on GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a report on Monday, June 8th. JPMorgan Chase & Co. dropped their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. HSBC decreased their price target on shares of GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Finally, Argus cut their target price on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, May 19th. Ten research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average target price of $77.73.

GE HealthCare Technologies Stock Up 1.0%

Shares of GE HealthCare Technologies stock opened at $74.82 on Friday. The firm has a market cap of $33.80 billion, a price-to-earnings ratio of 17.16, a P/E/G ratio of 2.16 and a beta of 0.69. The stock has a 50-day simple moving average of $66.61 and a 200-day simple moving average of $69.60. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09. The firm had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The firm’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.06 earnings per share. On average, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 24th were given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 24th. GE HealthCare Technologies’s payout ratio is currently 3.21%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.